Clinical trial
Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) A Randomized, Open Label, Phase III Study by Fondazione Italiana Linfomi.
NCT04442412 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) A Randomized, Open Label, Phase III Study by Fondazione Italiana Linfomi.
- Lead sponsor
- Fondazione Italiana Linfomi - ETS
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- March 23, 2021
- Completion date
- September 1, 2030
- Enrollment
- 430 (estimated)
- Sites
- 49
Conditions
As the registry lists them; a condition with its own page is linked.
diffuse large b-cell lymphoma, elderly patients